Advances in the first line treatment of pancreatic cancer

Results of the MPACT Trial (weekly nab-paclitaxel plus gemcitabine versus gemcitabine alone) in patients with metastatic pancreatic cancer will be reviewed, with emphasis on patient selection and neur... Author: oncologyeducation Added: 09/22/2014
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts